CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SPACEPHARMA aims to establish the first manufacturing facility for monoclonal antibodies in space, utilizing the unique conditions of microgravity to enhance the quality of biochemical products. This initiative seeks to revolutionize drug development by shortening timelines and reducing costs for pharmaceutical compani…
Over 2,000 R&D experiments have been done in Space until now.
Space near-zero gravity yields biochemical crystals orders of magnitude more defined, pure, uniform, and precise than in terrestial environments.
The low-gravity accelerates the development and preclinical testing of complex molecules e.g. proteins- and unleashes the potential of innovative high-value mAbs therapies, saving patients lives and improving their QoL.To make it real, after 11 space missions, SPACEPHARMA is committed to bri…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
